Advertisement

Intensive Care Medicine

, Volume 37, Issue 7, pp 1136–1142 | Cite as

Eosinopenia, an early marker of increased mortality in critically ill medical patients

  • Khalid Abidi
  • Jihane Belayachi
  • Youssef Derras
  • Mina El Khayari
  • Tarek Dendane
  • Naoufel Madani
  • Ibtissam Khoudri
  • Amine Ali Zeggwagh
  • Redouane AbouqalEmail author
Original

Abstract

Purpose

Inflammatory markers may have a role in predicting severity of illness of intensive care unit (ICU) patients. The aim of this study is to determine whether low eosinophil count can predict 28-day mortality in medical ICU.

Methods

A prospective study over a 4-month period. To evaluate the prognosis information provided by eosinophil count, we compared the variations in eosinophil count from ICU admission to seventh day between patients who survived and those who died. The best cutoff value was chosen using Younden’s index for identification of patients with high risk of mortality. The patient outcome was 28-day mortality.

Results

A total of 200 patients were eligible. Overall 28-day ICU mortality was 28% (n = 56). At ICU admission, the median eosinophil count was significantly different in survivors [30 cells/mm³; interquartile range (IQR), 0–100 cells/mm³] and nonsurvivors (0 cells/mm³; IQR, 0–30 cells/mm³; P = 0.004). Absolute eosinophil counts remained significantly lower in nonsurvivors from admission to seventh day. The 28-day mortality was significantly higher in patients with eosinopenia <40 cells/mm3 (P = 0.011). Multivariate analysis by Cox model with time-dependent covariates demonstrated that eosinophil count <40 cells/mm3 [hazard ratio (HR), 1.85; 95% confidence interval (CI), 1.01–3.42; P = 0.046], high Acute Physiology and Chronic Health Evaluation (APACHE) II score (HR, 1.08; 95% CI, 1.01–1.14; P = 0.014), high Sequential Organ Failure Assessment (SOFA) score (HR, 1.14; 95% CI, 1.03–1.25; P = 0.008), and use of mechanical ventilation (HR, 27.48; 95% CI, 12.12–62.28; P < 0.001) were independent predictors of 28-day all-cause mortality.

Conclusion

This study suggests the possibility to use eosinophil cell count at admission and during the first 7 days as a prognosis marker of mortality in medical ICU.

Keywords

Eosinopenia Intensive care unit Mortality Prognosis 

Notes

Conflict of interest

The authors declare that they have no conflict of interests.

References

  1. 1.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II A severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRefGoogle Scholar
  2. 2.
    Vincent JL, De Mendonca A, Cantrauine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of multicenter prospective study. Crit Care Med 26:1793–1800PubMedCrossRefGoogle Scholar
  3. 3.
    Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on European/Nort American multicenter study. JAMA 270:2957–2963PubMedCrossRefGoogle Scholar
  4. 4.
    Marshal JC, Cook DJ, Christou NV (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652CrossRefGoogle Scholar
  5. 5.
    Le Gall JR, Kler J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA 276:802–810PubMedCrossRefGoogle Scholar
  6. 6.
    Afessa B, Keegan MT, Mohammed Z, Finkielman JD, Peters SG (2004) Identifying potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 126:1905–1909PubMedCrossRefGoogle Scholar
  7. 7.
    Baughman RP, Lower EE, Flessa HC, Tollerud DJ (1993) Thrombocytopenia in the intensive care unit. Chest 104:1243–1247PubMedCrossRefGoogle Scholar
  8. 8.
    Stephan F, Hollande J, Richard O, Bonnet F (1999) Thrombocytopenia in a surgical ICU. Chest 115:1363–1370PubMedCrossRefGoogle Scholar
  9. 9.
    Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871–1876PubMedCrossRefGoogle Scholar
  10. 10.
    Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, Lassence AD, Zahar JR, Adrie C, Vincent F, Cohen Y, Schlemmer B, Azoulay E (2007) Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 131:1735–1741PubMedCrossRefGoogle Scholar
  11. 11.
    Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596–2602PubMedCrossRefGoogle Scholar
  12. 12.
    Lobo SMA, Lobo FRM, Bota DP, lopes-Ferreira F, Soliman HM, Mélot C, Vincent JL (2003) C-reactive protein levels correlate with patients mortality and organ failure in critically ill. Chest 123:2043–2049PubMedCrossRefGoogle Scholar
  13. 13.
    Lopes-Ferreira F, Peres D, Bross A (2000) Serial evaluations of the SOFA score to predict outcome. JAMA 286:1754–1758CrossRefGoogle Scholar
  14. 14.
    Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE (1980) Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 65:1265–1271PubMedCrossRefGoogle Scholar
  15. 15.
    Zappert J (1983) Ueber das vorkommen der eosinophilen zellen in menschlichen blute. Z Klin Med 23:227–308Google Scholar
  16. 16.
    Simon CE (1922) A manual of clinical diagnosis. Henry Klimpton, London 53Google Scholar
  17. 17.
    Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R (2008) Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 12:R59PubMedCrossRefGoogle Scholar
  18. 18.
    Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M (2010) Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of obstructive pulmonary disease. Respirology 15:165–167PubMedCrossRefGoogle Scholar
  19. 19.
    Charlson ME, Pompei P, Ales Kl, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRefGoogle Scholar
  20. 20.
    Bone RC, Balk RA, Cerra Fb, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) American college of chest physicians/society of critical care medicine consensus conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMedCrossRefGoogle Scholar
  21. 21.
    Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, Niederman MS, Torres A (1998) Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 158:1102–1108PubMedGoogle Scholar
  22. 22.
    Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–220Google Scholar
  23. 23.
    Crowley J, Hu M (1977) Covariance analysis of heart transplant survival data. J Am Stat Assoc 72:27–36CrossRefGoogle Scholar
  24. 24.
    Therneau TM, Grambsch PM (2000) Modelling survival data: extending the Cox model. Springer, New YorkGoogle Scholar
  25. 25.
    Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709–750PubMedCrossRefGoogle Scholar
  26. 26.
    Bass DA (1977) Reproduction of the eosinopenia of acute infection by passive transfer of a material obtained from inflammatory exudate. Infect Immun 15:410–416PubMedGoogle Scholar
  27. 27.
    Rothenberg ME (1998) Eosinophilia. N Engl J Med 338:1592–1600PubMedCrossRefGoogle Scholar
  28. 28.
    Bass DA (1975) Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 56:870–879PubMedCrossRefGoogle Scholar
  29. 29.
    Gil H, Magy N, Mauny F, Dupond JL (2003) Value of eosinopenia in inflammatory disorders: an ‘old’ marker revisited. Rev Med Interne 24:431–435PubMedCrossRefGoogle Scholar
  30. 30.
    Smithson A, Perello R, Nicolas JM (2009) Is eosinopenia a reliable marker of sepsis? Crit Care 13:409PubMedCrossRefGoogle Scholar
  31. 31.
    Setterberg MJ, Newman W, Potti A, Smego RA (2004) Utility of eosinophil count as predictor of bacteremia. Clin Infect Dis 38:460–461PubMedCrossRefGoogle Scholar
  32. 32.
    Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, Metnitz PG (2009) Austrian validation and customization of the SAPS 3 admission score. Intensive Care Med 35:616–622PubMedCrossRefGoogle Scholar
  33. 33.
    Hardy JD (1950) The role of the adrenal cortex in the postoperative retention of salt and water. Ann Surg 132:189–197PubMedGoogle Scholar
  34. 34.
    Evans EI, Butterfield WJH (1951) The stress response in the severely burned: an interim report. Ann Surg 134:588–611PubMedGoogle Scholar
  35. 35.
    Sevitt S (1955) The spleen and blood eosinopenia. J Clin Pathol 8:42–46PubMedCrossRefGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2011

Authors and Affiliations

  • Khalid Abidi
    • 1
  • Jihane Belayachi
    • 1
  • Youssef Derras
    • 1
  • Mina El Khayari
    • 1
  • Tarek Dendane
    • 1
  • Naoufel Madani
    • 1
  • Ibtissam Khoudri
    • 1
  • Amine Ali Zeggwagh
    • 1
    • 2
  • Redouane Abouqal
    • 1
    • 2
    Email author
  1. 1.Medical Intensive Care UnitIbn Sina University HospitalRabatMorocco
  2. 2.Laboratory of Biostatistics, Clinical and Epidemiological Research, Faculté de Médecine et PharmacieUniversité Mohamed VRabatMorocco

Personalised recommendations